E3 PreliminaryPreliminaryPEM not requiredReview-NarrativePeer-reviewedReviewed
Standard · 3 min
Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19.
Soares, Madu N, Eggelbusch, Moritz, Naddaf, Elie et al. · Journal of cachexia, sarcopenia and muscle · 2022 · DOI
Quick Summary
Many people with COVID-19 and long COVID experience muscle weakness and tiredness, especially after physical activity. This review examines what happens inside muscle cells in these patients, including muscle fiber shrinkage, changes in how muscles use energy, and immune cell buildup. The authors suggest that severe illness, lack of activity, low oxygen levels, and poor nutrition all contribute to these problems, similar to what happens in other serious conditions.
Why It Matters
This review is important for ME/CFS patients and researchers because it draws explicit comparisons between PASC-related muscle dysfunction and chronic fatigue syndrome, two conditions with overlapping symptoms of unexplained weakness and exercise intolerance. Understanding the cellular mechanisms of post-viral muscle dysfunction in COVID-19 may illuminate similar processes in ME/CFS and inform potential therapeutic approaches.
Observed Findings
Histological sections from severe COVID-19 and PASC patients show muscle fiber atrophy, metabolic alterations, and immune cell infiltration
Skeletal muscle weakness and exercise intolerance occur in both acute severe COVID-19 and PASC
Severe COVID-19 muscle dysfunction is associated with systemic inflammation, disuse, hypoxemia, and malnutrition
The mechanisms underlying PASC-associated muscle weakness are less well understood than acute COVID-19-related weakness
Similarities exist between muscle alterations in PASC and those reported in chronic fatigue syndrome
Inferred Conclusions
Both SARS-CoV-2-specific factors and generic consequences of acute systemic illness likely contribute to skeletal muscle alterations in COVID-19
Direct viral infiltration of skeletal muscle or aberrant immune system responses may explain the more persistent muscle dysfunction seen in PASC
PASC-related muscle dysfunction shares features with critical illness myopathy and may have parallels to post-viral fatigue syndrome and chronic fatigue syndrome
Further study is needed to elucidate the distinctive mechanisms of PASC muscle dysfunction compared to acute COVID-19
Remaining Questions
What specific mechanisms distinguish PASC-associated muscle dysfunction from acute COVID-19-related weakness?
What This Study Does Not Prove
This narrative review does not establish causal mechanisms or provide definitive proof that PASC and ME/CFS share identical pathophysiological pathways. It cannot prove that specific viral or immune factors directly cause muscle dysfunction, as these remain areas of ongoing investigation. The review synthesizes existing literature rather than presenting new experimental or clinical trial data, so its conclusions are only as strong as the evidence base it summarizes.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.